About Biosolution
Cosmetic labs in South Korea reach new heights with Biosolution, a biotechnology leader headquartered at Seoul Technopark specializing in cell therapy and tissue engineering. With facilities in Seoul and Suwon city, the company offers:
- Cell therapy product manufacturing
- Human tissue model development
- Medical device quality systems (ISO 13485:2016 certified)
- Biotech manufacturing solutions
As a publicly traded company on the Korean Exchange (KRX:086820), Biosolution drives innovation in regenerative medicine and medical technology across the Korean peninsula.
Frequently asked questions
Biosolution operates in these key areas:
- Cell Therapy Products
- Cell-based therapeutic solutions
- Regenerative medicine applications
- Tissue engineering products
- Human Tissue Models
- 3D tissue constructs
- In-vitro testing platforms
- Research applications
- Medical Device Development
- ISO 13485:2016 certified processes
- Quality management systems
- Biotech manufacturing
The company maintains ISO certification for medical device quality management systems.
Biosolution maintains these operational frameworks:
| Category | Components |
|---|---|
| Quality Systems |
|
| Research Capabilities |
|
| Production Assets |
|
Biosolution operates from two facilities in South Korea:
Main HeadquartersSeoul Technopark
Seoul, South Korea Manufacturing Facility
Suwon city
Kyounggi-Do, South Korea
The facilities house:
- Research laboratories
- Manufacturing units
- Quality control centers
- Administrative offices
Stock listing: Korean Exchange (KRX)
Trading Symbol: 086820.KQ
More details about Biosolution
Leading biotechnology innovation in South Korea
Biosolution stands as a prominent player in South Korea’s biotechnology sector. Operating as a cosmetic lab and biotech manufacturer, the company combines scientific expertise with advanced research capabilities to develop innovative solutions.
Specialized services and expertise
At the core of Biosolution’s operations lies its dedication to cell therapy and tissue engineering. The company’s portfolio includes:
- Development of human tissue models
- Manufacturing of cell-based products
- Medical device solutions
- Quality management systems implementation
Quality standards and certifications
Biosolution maintains ISO 13485:2016 certification, validating its commitment to quality in medical device manufacturing and management systems. This certification supports the company’s position in both domestic and international markets.
Strategic locations in South Korea
The company operates from two key locations:
- Main headquarters at Seoul Technopark, positioning the company within South Korea’s primary technology hub
- Additional research and manufacturing facility in Suwon city, Kyounggi-Do
Market presence and recognition
As a publicly traded company on the Korean Exchange (KRX: 086820.KQ), Biosolution maintains transparency and accountability in its operations. The company’s presence in the biotech manufacturing sector continues to grow, supported by its focus on regenerative medicine and medical technology advancement.
Company gallery
